Monday, January 10, 2022 8:27:37 AM
SANTA BARBARA, CA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTC:HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today announced the appointment of Dr. Syed Mubeen to the role of Chief Scientific Officer (CSO).
Dr. Mubeen, a University of Iowa Chemical Engineering Professor, has served as a lead scientist for SunHydrogen since 2015. His expertise is in the intersection of nanotechnology and electrochemical engineering, specifically in the areas of solar fuel and chemical production. At the University of Iowa, Dr. Mubeen also directed graduate admissions for the chemical engineering program. He has authored more than 50 peer-reviewed papers on electrochemistry and his work has been cited over 5500 times.
With his new role as SunHydrogen CSO in effect as of January 1, Dr. Mubeen has taken a leave of absence from the University of Iowa and assumed full-time duties with SunHydrogen.
As CSO, Dr. Mubeen will collaborate with SunHydrogen’s team and development partners to advance the company's nanoparticle-based hydrogen generation technology. He will also assist Director of Technology Dr. Joun Lee and the larger senior management team with the expansion of scientific staff and research capabilities for the production and scale-up of SunHydrogen’s technology.
“Dr. Mubeen has been instrumental to SunHydrogen's progress, and our team is thankful for the opportunity to work even more closely with him," said SunHydrogen CEO Tim Young.
Recent HYSR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2024 05:15:09 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 01/25/2024 09:40:59 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/24/2024 09:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2023 09:03:04 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:33:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:13:34 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM